JP2025503646A - うつ病の治療のための組成物及び方法 - Google Patents

うつ病の治療のための組成物及び方法 Download PDF

Info

Publication number
JP2025503646A
JP2025503646A JP2024541193A JP2024541193A JP2025503646A JP 2025503646 A JP2025503646 A JP 2025503646A JP 2024541193 A JP2024541193 A JP 2024541193A JP 2024541193 A JP2024541193 A JP 2024541193A JP 2025503646 A JP2025503646 A JP 2025503646A
Authority
JP
Japan
Prior art keywords
level
patient
dynorphin
treatment
aticaplant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541193A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503646A5 (https=
JPWO2023131920A5 (https=
Inventor
シー． ドレヴェッツ，ウェイン
クリスチャン コルブ，ハートマス
サーハル サード，ジアド
ワン，ティナ
Original Assignee
ヤンセン ファーマシューティカルズ，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤンセン ファーマシューティカルズ，インコーポレーテッド filed Critical ヤンセン ファーマシューティカルズ，インコーポレーテッド
Publication of JP2025503646A publication Critical patent/JP2025503646A/ja
Publication of JP2025503646A5 publication Critical patent/JP2025503646A5/ja
Publication of JPWO2023131920A5 publication Critical patent/JPWO2023131920A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024541193A 2022-01-10 2023-01-09 うつ病の治療のための組成物及び方法 Pending JP2025503646A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263298047P 2022-01-10 2022-01-10
US63/298,047 2022-01-10
PCT/IB2023/050170 WO2023131920A1 (en) 2022-01-10 2023-01-09 Compositions and methods for the treatment of depression

Publications (3)

Publication Number Publication Date
JP2025503646A true JP2025503646A (ja) 2025-02-04
JP2025503646A5 JP2025503646A5 (https=) 2026-01-16
JPWO2023131920A5 JPWO2023131920A5 (https=) 2026-01-16

Family

ID=84981555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541193A Pending JP2025503646A (ja) 2022-01-10 2023-01-09 うつ病の治療のための組成物及び方法

Country Status (10)

Country Link
US (1) US20250221960A1 (https=)
EP (1) EP4463152A1 (https=)
JP (1) JP2025503646A (https=)
KR (1) KR20240132479A (https=)
CN (1) CN118510507A (https=)
AU (1) AU2023205471A1 (https=)
CA (1) CA3247760A1 (https=)
IL (1) IL314179A (https=)
MX (1) MX2024008618A (https=)
WO (1) WO2023131920A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024336807A1 (en) * 2023-09-06 2026-04-16 Janssen Pharmaceuticals, Inc. Compositions comprising aticaprant for use in treating major depressive disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5345637B2 (ja) * 2008-01-22 2013-11-20 イーライ リリー アンド カンパニー κ選択的オピオイド受容体アンタゴニスト

Also Published As

Publication number Publication date
EP4463152A1 (en) 2024-11-20
CN118510507A (zh) 2024-08-16
KR20240132479A (ko) 2024-09-03
WO2023131920A1 (en) 2023-07-13
IL314179A (en) 2024-09-01
CA3247760A1 (en) 2023-07-13
US20250221960A1 (en) 2025-07-10
AU2023205471A1 (en) 2024-08-29
MX2024008618A (es) 2024-09-25

Similar Documents

Publication Publication Date Title
JP2024516297A (ja) うつ病の治療のための組成物及び方法
US11266627B1 (en) Compositions and methods for the treatment of depression
US11998525B2 (en) Compositions and methods for the treatment of depression
CN104519878A (zh) 用于治疗顽固性或难治性抑郁症的艾氯胺酮
EA010430B1 (ru) Сочетание антагониста nmda-рецептора и селективного ингибитора обратного захвата серотонина для лечения депрессии и других психических расстройств
JP2025508069A (ja) アチカプラントを含む組成物
JP2025503646A (ja) うつ病の治療のための組成物及び方法
JP2025502098A (ja) うつ病の治療のための組成物及び方法
JP2025503649A (ja) うつ病の治療のための組成物及び方法
US20250177350A1 (en) Compositions and methods for the treatment of depression
US20240238245A1 (en) Compositions and methods for the treatment of depression
US20230084299A1 (en) Improved antidepressant therapy
CN117615757A (zh) 用于治疗抑郁症的组合物和方法
EA050800B1 (ru) Композиции и способы лечения депрессии
JP7840873B2 (ja) うつ病の治療方法
US20240358693A1 (en) Methods of treating pain
JP2012533547A (ja) 治療のためのエキソ−ｓ−メカミラミンの方法、使用、及び化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260107